{
  "id": 15087040,
  "title": "PTC Therapeutics director sells $149,036 in shares",
  "url": "https://urgent.news/2026/10/17/ptc-therapeutics-director-sells-149-036-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-17T01:01:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ptc-therapeutics-director-sells-149036-in-shares-93CH-4955076"
  },
  "original_language": "en",
  "account": "PTC Therapeutics' director Michael Schmertzler sold 2,500 shares of the company's common stock on October 14, 2026, according to an SEC Form 4 filing. The sale, executed under a Rule 10b5-1 trading plan, totaled $149,036 with share prices fluctuating between $59.52 and $60.14. Schmertzler, a general and limited partner of Section Six Partners, L.P., which owned the shares, sold 2,118 shares at an average price of $59.52 and 382 shares at an average price of $60.14. This left Section Six Partners with 1,291,594 shares of PTC Therapeutics stock. The insider sale occurred as PTCT shares approached a 52-week low of $58.80, experiencing a 22% decline year-to-date. Despite the company's current unprofitability, analysts anticipate profitability in the upcoming year. PTCT reported strong earnings in Q2 2026, exceeding expectations with $0.92 per share in earnings per share and $361 million in revenue. The company's acquisition of ST-920 from Sangamo and a raised price target from Cantor Fitzgerald contributed to this success. PTC Therapeutics remains well-positioned for growth with $2.23 billion in cash reserves.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Paul Mahon, United Therapeutics EVP, sells $4.5m in stock",
        "url": "https://urgent.news/2026/10/16/paul-mahon-united-therapeutics-evp-sells-4-5m-in-stock",
        "published": "2026-10-16T21:01:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}